<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25908" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nocardia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rathish</surname>
            <given-names>Balram</given-names>
          </name>
          <aff>Guy's and St Thomas' NHS Foundation Trust</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zito</surname>
            <given-names>Patrick M.</given-names>
          </name>
          <aff>University of Miami; Miller School of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Balram Rathish declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Patrick Zito declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25908.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The genus Nocardia is an aerobic actinomycete, catalase-positive, gram-positive bacillus, with a branching filamentous form that can cause pulmonary infection (most common), primary cutaneous infection and also dissemination to other sites. Typically, Nocardia is an opportunistic pathogen that primarily affects immunosuppressed patients. This activity reviews the evaluation and treatment of Nocardia infection and highlights the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify patients at high risk of developing nocardiosis.</p></list-item><list-item><p>Summarize the clinical presentations of nocardiosis based upon the infection site.</p></list-item><list-item><p>Outline the treatment and management options available for nocardiosis.</p></list-item><list-item><p>Review interprofessional team strategies for improving care coordination and communication to advance nocardiosis treatment and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25908&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25908">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25908.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The genus <italic toggle="yes">Nocardia</italic> is an aerobic actinomycete, catalase-positive, gram-positive bacillus, with a branching filamentous form first described in 1888 by Edmond Nocard.<xref ref-type="bibr" rid="article-25908.r1">[1]</xref><xref ref-type="bibr" rid="article-25908.r2">[2]</xref>&#x000a0;<italic toggle="yes">Nocardia</italic>
<italic toggle="yes">sp. </italic>is found worldwide in a myriad of environments.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref>&#x000a0;Disease resulting from <italic toggle="yes">Nocardia</italic> infection results in a variety of symptoms based upon the location of the infection. The classic sites of infection include pulmonary infection (most common) and primary cutaneous infection; however, dissemination to other sites and CNS involvement often occurs.<xref ref-type="bibr" rid="article-25908.r2">[2]</xref><xref ref-type="bibr" rid="article-25908.r4">[4]</xref>&#x000a0;Typically, <italic toggle="yes">Nocardia</italic> is an opportunistic pathogen that primarily affects immunosuppressed patients.<xref ref-type="bibr" rid="article-25908.r2">[2]</xref><xref ref-type="bibr" rid="article-25908.r3">[3]</xref>&#x000a0;However, <italic toggle="yes">Nocardia</italic> can also infect immunocompetent individuals, especially the cutaneous form of the disease.</p>
      </sec>
      <sec id="article-25908.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Nocardia</italic>&#x000a0;has been reported to be found&#x000a0;ubiquitously in the environment and has been cultured from both fresh and saltwater, dust, soil, decaying vegetation, and decaying organic matter.<xref ref-type="bibr" rid="article-25908.r2">[2]</xref><xref ref-type="bibr" rid="article-25908.r5">[5]</xref><xref ref-type="bibr" rid="article-25908.r6">[6]</xref>&#x000a0;The majority of <italic toggle="yes">Nocardia</italic> infections are thought to be due to inhalation of bacteria via environmental sources (i.e., dust), leading to the most common form of the infection, pulmonary nocardiosis.<xref ref-type="bibr" rid="article-25908.r5">[5]</xref></p>
        <p>Contrastingly, cutaneous nocardiosis arises via the inoculation of traumatic skin lesions. Other methods of infection that have been implicated include hospitalized acquired infections where clusters of nocardiosis have been described, and infection is transmitted from central venous catheters.<xref ref-type="bibr" rid="article-25908.r7">[7]</xref><xref ref-type="bibr" rid="article-25908.r8">[8]</xref>&#x000a0;Once a patient has a <italic toggle="yes">Nocardia</italic> infection, whether symptomatic or asymptomatic, it can spread hematogenously or by local extensions. Overall, immunocompromised individuals are more susceptible to nocardiosis and disseminated spread.</p>
      </sec>
      <sec id="article-25908.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The CDC reports the incidence of nocardiosis in the US as 500-1000 cases per year. Globally, the incidence of <italic toggle="yes">Nocardia</italic> infection is not well known. The incidence of nocardiosis is thought to be increasing due to an increasing population and an increased number of immunocompromised individuals worldwide.<xref ref-type="bibr" rid="article-25908.r1">[1]</xref><xref ref-type="bibr" rid="article-25908.r9">[9]</xref><xref ref-type="bibr" rid="article-25908.r10">[10]</xref> Nocardiosis affects all ages and races but is more common in males than females in a 3&#x000a0;to 1 ratio. <italic toggle="yes">Nocardia </italic>typically manifests as an opportunistic infection in immunocompromised patients, with 60% of patients with nocardiosis having immunosuppressive conditions.<xref ref-type="bibr" rid="article-25908.r2">[2]</xref><xref ref-type="bibr" rid="article-25908.r6">[6]</xref><xref ref-type="bibr" rid="article-25908.r11">[11]</xref>&#x000a0;However, up to 33% of patients are immunocompetent; this is especially true of cutaneous infections where immunocompetent individuals are the majority of cases.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r5">[5]</xref><xref ref-type="bibr" rid="article-25908.r12">[12]</xref> Dissemination of both cutaneous and pulmonary nocardiosis is more likely in immunocompromised hosts.</p>
        <p>Immunocompromised conditions associated with <italic toggle="yes">Nocardia</italic> infections include:</p>
        <list list-type="bullet">
          <list-item>
            <p>HIV (most common underlying condition)<xref ref-type="bibr" rid="article-25908.r13">[13]</xref><xref ref-type="bibr" rid="article-25908.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Cancer</p>
          </list-item>
          <list-item>
            <p>Chemotherapy treatment</p>
          </list-item>
          <list-item>
            <p>Corticosteroid treatment (present in more than half of patients with <italic toggle="yes">Nocardia </italic>infection according to one report)<xref ref-type="bibr" rid="article-25908.r13">[13]</xref><xref ref-type="bibr" rid="article-25908.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Solid organ transplant recipients (especially lung transplant)<xref ref-type="bibr" rid="article-25908.r15">[15]</xref></p>
          </list-item>
          <list-item>
            <p>Allogenic hematopoietic stem cell transplant recipients<xref ref-type="bibr" rid="article-25908.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Diabetes</p>
          </list-item>
          <list-item>
            <p>Autoimmune diseases&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Chronic lung diseases such as COPD (many patients on corticosteroid therapy)<xref ref-type="bibr" rid="article-25908.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p>Any condition that results in deficient cell-mediated immunity</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25908.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Found commonly in soil, presentations of <italic toggle="yes">Nocardia</italic> are:</p>
        <list list-type="order">
          <list-item>
            <p>Primary cutaneous nocardiosis</p>
          </list-item>
          <list-item>
            <p>Cellulitic and sporotrichoid forms</p>
          </list-item>
          <list-item>
            <p>Actinomycetoma</p>
          </list-item>
          <list-item>
            <p>Disseminated disease (most common secondary to pulmonary involvement)</p>
          </list-item>
        </list>
        <p>The most common form of <italic toggle="yes">Nocardia</italic> infection is pulmonary, and most common causing human infection are:</p>
        <list list-type="bullet">
          <list-item>
            <p>
<italic toggle="yes">N. asteroides</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">N. brasiliensis</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">N. caviae</italic>
</p>
          </list-item>
        </list>
        <p><italic toggle="yes">Nocardia sp.&#x000a0;</italic>is a member of the family <italic toggle="yes">Nocardiaceae</italic> (along with the genus <italic toggle="yes">Rhodococcus</italic>), belonging to the &#x0201c;aerobic actinomycetes&#x0201d; suborder.&#x000a0;Currently, the genus <italic toggle="yes">Nocardia </italic>contains 80-100 species, of these, more than fifty have been implicated as human or animal pathogens.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r18">[18]</xref>&#x000a0; Historically, <italic toggle="yes">Nocardia asteroides </italic>was implicated as the most common cause of numerous <italic toggle="yes">Nocardial </italic>human infections. However, it was later found to be a group of bacteria that have been further classified into separate species.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r5">[5]</xref>&#x000a0;Various <italic toggle="yes">Nocardia </italic>species have been shown to be more prevalent in specific geographic locations. For example, <italic toggle="yes">Nocardia brasiliensis, </italic>a species associated with cutaneous infections (80% of all cutaneous <italic toggle="yes">Nocardia</italic> infection), is found more frequently in tropical and sub-tropical climates.<xref ref-type="bibr" rid="article-25908.r2">[2]</xref>&#x000a0;<italic toggle="yes">Nocardia </italic>infections vary significantly in symptomatology based on the site of infection. However, <italic toggle="yes">Nocardia </italic>typically produces suppurative necrosis with frequent abscess formation at most sites of infection, including pulmonary, cutaneous, and CNS.&#x000a0; That being said, <italic toggle="yes">Nocardia </italic>also can form cavitary lesions, skin nodules, and cellulitis making diagnosis difficult as it is similar to many other bacterial and fungal infections.</p>
        <p>Primary cutaneous nocardiosis is most commonly caused by&#x000a0;<italic toggle="yes">N. brasiliensis.&#x000a0;</italic>Cutaneous nocardiosis from&#x000a0;<italic toggle="yes">N. asteroides</italic> is usually secondary to hematogenous dissemination. Primary cutaneous nocardiosis is divided into three entities:</p>
        <list list-type="order">
          <list-item>
            <p>Lymphocutaneous infection (often misdiagnosed for sporotrichosis)</p>
          </list-item>
          <list-item>
            <p>Mycetoma</p>
          </list-item>
          <list-item>
            <p>Superficial skin infection (ulceration, abscess, cellulitis)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25908.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The characteristic morphology of <italic toggle="yes">Nocardia </italic>is a branching, filamentous, gram-positive rod when observed under the microscope.&#x000a0;<italic toggle="yes">Nocardia</italic> can resemble <italic toggle="yes">Actinomyces</italic> species on gram stain.&#x000a0; However,&#x000a0;<italic toggle="yes">Nocardia</italic> is an obligate aerobe that stains weakly positive on acid-fast staining.<xref ref-type="bibr" rid="article-25908.r1">[1]</xref>&#x000a0;&#x000a0;</p>
        <p><italic toggle="yes">Nocardia </italic>is typically weakly acid-fast after traditional carbol-fuchsin staining and positive on modified acid-fast staining due to the presence of mycolic acid in the cell wall. Unlike mycobacteria (also acid-fast positive),&#x000a0;<italic toggle="yes">Nocardia </italic>has a &#x0201c;beaded&#x0201d; appearance on acid-fast staining.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref>&#x000a0;<italic toggle="yes">Nocardia</italic> is catalase-positive and urease positive.</p>
      </sec>
      <sec id="article-25908.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p><italic toggle="yes">Nocardia</italic> has low virulence, and so clinically significant disease occurs in patients with immunosuppression or weak immune systems. The virulence factors of <italic toggle="yes">Nocardia</italic> are the enzymes catalase and superoxide dismutase, which inactivates reactive oxygen species toxic to the bacteria produced by neutrophils.<xref ref-type="bibr" rid="article-25908.r2">[2]</xref>&#x000a0;Thus, patients with chronic granulomatous disease are susceptible to <italic toggle="yes">Nocardia </italic>infections. <italic toggle="yes">Nocardia </italic>also has &#x0201c;cord factor&#x0201d; similar to <italic toggle="yes">Mycobacterium tuberculosis</italic> preventing the fusion of phagosomes with lysosomes.<xref ref-type="bibr" rid="article-25908.r19">[19]</xref><xref ref-type="bibr" rid="article-25908.r20">[20]</xref></p>
      </sec>
      <sec id="article-25908.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The symptoms of nocardiosis vary depending on where the site of infection is. Patients with pulmonary nocardiosis&#x000a0;can present with fever, weight loss, night sweats, cough, and chest pain. If the infection spreads to the CNS, symptoms can include headache, weakness, confusion, and seizures. Cutaneous nocardiosis can present with skin ulcers, nodules&#x000a0;that are sometimes draining,&#x000a0;and the infection can spread to the lymph nodes.</p>
        <p>Delay in the diagnosis of an immunosuppressed patient with nocardiosis has been implicated in treatment failure and poor prognosis. Therefore, if there is suspicion for infection with <italic toggle="yes">Nocardia,</italic> it is imperative to notify the laboratory of this suspicion so that steps can be taken by the laboratory to identify the species and antibiotic sensitivity pattern.</p>
      </sec>
      <sec id="article-25908.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Nocardiosis is a challenge to diagnose due to its non-specific findings and imaging that can suggest many different diagnoses (see DDX section). The diagnosis of nocardiosis is established with a culture of the causative organism from the infection site. Common culture samples include sputum, skin biopsy, abscess aspirates, or a sample from bronchoalveolar lavage. It can take several days (3-5 days) to isolate <italic toggle="yes">Nocardia</italic> in culture. Blood cultures for Nocardemia should be drawn in instances of pulmonary or disseminated disease, although <italic toggle="yes">Nocardia</italic> bacteremia is very rare.<xref ref-type="bibr" rid="article-25908.r21">[21]</xref>&#x000a0;</p>
        <p>Imaging via computed tomography (CT) or chest radiograph is a valuable diagnostic tool, especially in evaluating pulmonary nocardiosis. However, findings vary significantly and can include irregular nodules (can be cavitary), diffuse pulmonary infiltrates, lung abscesses, or pleural effusion.&#x000a0;Imaging findings help support a history and physical exam that may be concerning for nocardiosis.</p>
        <p>All patients with nocardiosis (except those with mycetoma) should undergo brain CT or magnetic resonance imaging (MRI). If the primary infection spreads, the CNS is the most common location (44% of the time).<xref ref-type="bibr" rid="article-25908.r6">[6]</xref>&#x000a0;An intracranial abscess is the most common abnormality found on imaging.<italic toggle="yes">&#x000a0; </italic>If concerned for nocardial meningitis, a lumbar puncture should be performed, and CNS analysis conducted. Nocardial meningitis is rare but presents similar to other bacterial meningitis.<xref ref-type="bibr" rid="article-25908.r22">[22]</xref><xref ref-type="bibr" rid="article-25908.r23">[23]</xref></p>
        <p>It is important to notify the laboratory when suspecting Nocardia as a possible infection. This will allow for gram staining and modified acid-fast staining helping to confirm diagnosis as soon as possible. This is especially important as it can take several days to culture&#x000a0;<italic toggle="yes">Nocardia&#x000a0;</italic>species. Similarly, this will help aid in initial treatment prior to obtaining antibiotic susceptibility patterns. The recent development of more rapid and precise PCR and 16S rDNA sequencing to identify <italic toggle="yes">Nocardia</italic> species may allow for faster diagnosis and treatment of nocardiosis.<xref ref-type="bibr" rid="article-25908.r24">[24]</xref></p>
      </sec>
      <sec id="article-25908.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Since the 1940s, the mainstay treatment for <italic toggle="yes">Nocardia</italic> infections has been sulfonamides, the most common of which in the U.S. is trimethoprim-sulfamethoxazole (TMP-SMX).<xref ref-type="bibr" rid="article-25908.r2">[2]</xref><xref ref-type="bibr" rid="article-25908.r5">[5]</xref><xref ref-type="bibr" rid="article-25908.r25">[25]</xref><xref ref-type="bibr" rid="article-25908.r26">[26]</xref>&#x000a0;Resistance to TMP-SMX as a single agent has been shown to be species-dependent with <italic toggle="yes">N. farcinica</italic>, <italic toggle="yes">N. nova</italic>, and <italic toggle="yes">N. otitidiscaviarum&#x000a0;</italic>showing increased multi-drug resistance.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r26">[26]</xref>&#x000a0;Due to this resistance, most clinicians now administer combination drug therapy, especially for patients with a serious infection, disseminated disease, or CNS involvement. The most common regiment includes TMP-SMX, amikacin, and imipenem.&#x000a0;However, if the patient has CNS involvement, it is important to pick agents with good CNS penetration, such as TMP-SMX and ceftriaxone.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r27">[27]</xref>&#x000a0; More recently, the oxazolidinone, linezolid, has been shown to have excellent coverage against all known pathogenic <italic toggle="yes">Nocardia</italic> species.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r5">[5]</xref></p>
        <p>Other agents to consider include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Carbapenems: imipenem, meropenem, or ertapenem, with imipenem having the best efficacy</p>
          </list-item>
          <list-item>
            <p>Quinolones: especially moxifloxacin</p>
          </list-item>
          <list-item>
            <p>Tetracyclines: minocycline</p>
          </list-item>
        </list>
        <p>The duration of treatment is dependent on the location of infection and the immune status of the affected individual. For patients with pulmonary or multifocal disease that does not involve the CNS, a treatment regimen for 6-12 months is indicated. If the patient is immunosuppressed or has CNS involvement, they should be treated for a minimum of 12 months.<xref ref-type="bibr" rid="article-25908.r3">[3]</xref></p>
        <p>Prophylaxis<italic toggle="yes">:</italic><bold><italic toggle="yes">&#x000a0;</italic></bold>Patients shown to be at greatest risk for <italic toggle="yes">Nocardia </italic>infection have been documented to be patients that are HIV positive.<xref ref-type="bibr" rid="article-25908.r13">[13]</xref><xref ref-type="bibr" rid="article-25908.r14">[14]</xref> Commonly, TMP-SMX is used as prophylaxis in HIV patients for coverage against <italic toggle="yes">Pneumocystis jiroveci</italic> pneumonia (PJP) or <italic toggle="yes">Toxoplasma gondii</italic>.&#x000a0; Fortunately, this prophylaxis also has been shown to help reduce <italic toggle="yes">Nocardia </italic>infections.</p>
      </sec>
      <sec id="article-25908.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p><italic toggle="yes">Nocardia </italic>is extremely difficult to differentiate from other infectious etiologies. The differential diagnosis for primary sites of infection are outlined below:<xref ref-type="bibr" rid="article-25908.r3">[3]</xref><xref ref-type="bibr" rid="article-25908.r10">[10]</xref></p>
        <p>Pulmonary disease</p>
        <list list-type="bullet">
          <list-item>
            <p>Fungal infections &#x02013; aspergillosis, mucormycosis, histoplasmosis, blastomycosis, and cryptococcosis</p>
          </list-item>
          <list-item>
            <p>Actinomyces infection</p>
          </list-item>
          <list-item>
            <p>Mycobacterial infections &#x02013; including <italic toggle="yes">Mycobacterium tuberculosis</italic></p>
          </list-item>
          <list-item>
            <p>Lung malignancy</p>
          </list-item>
        </list>
        <p>Cutaneous disease</p>
        <list list-type="bullet">
          <list-item>
            <p>Superficial cellulitis &#x02013; group A strep (GAS), staph aureus</p>
          </list-item>
          <list-item>
            <p>Lymphocutaneous &#x02013; sporotrichosis, <italic toggle="yes">Mycobacterium marinum</italic></p>
          </list-item>
          <list-item>
            <p>Mycetoma (late-stage) &#x02013; actinomycosis, fungal infections</p>
          </list-item>
          <list-item>
            <p>Other: cutaneous leishmaniasis, <italic toggle="yes">Cryptococcus</italic></p>
          </list-item>
        </list>
        <p>CNS disease</p>
        <list list-type="bullet">
          <list-item>
            <p>Malignancy</p>
          </list-item>
          <list-item>
            <p>Bacterial abscess</p>
          </list-item>
          <list-item>
            <p>Vascular infarction</p>
          </list-item>
          <list-item>
            <p>Other: toxoplasmosis, mycobacterial tuberculosis, fungal infection, cysticercosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25908.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The morbidity and mortality of <italic toggle="yes">Nocardia</italic> depend on the site and extent of infection as well as underlying host factors. Prognosis varies based on the site of infection.<xref ref-type="bibr" rid="article-25908.r28">[28]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Skin and soft tissue infections: approximately 100% cured</p>
          </list-item>
          <list-item>
            <p>Pleuropulmonary infections: approximately 80% cured
<list list-type="bullet"><list-item><p>In the 1940s, pulmonary nocardiosis had a fatality rate of 100%, but with the advent of sulfonamide antibiotics and more recently combined antibiotic therapy, the mortality has decreased dramatically.<xref ref-type="bibr" rid="article-25908.r5">[5]</xref> Currently, mortality rates of pulmonary nocardiosis are anywhere from 14%&#x000a0;to 40%.<xref ref-type="bibr" rid="article-25908.r10">[10]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Disseminated nocardiosis: 3% cured</p>
          </list-item>
          <list-item>
            <p>CNS involvement: 50%&#x000a0;to 85% cure rate<xref ref-type="bibr" rid="article-25908.r29">[29]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25908.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Complications can arise due to the spread from the primary site of infection. This is especially true of pulmonary nocardiosis that has spread locally. This can result in pericarditis and superior vena cava (SVC) syndrome depending upon the location and extent of spread. Additionally, the risk of spread to the CNS results in a multitude of possible complications, including focal neurologic deficits and meningitis.&#x000a0;Delay in the diagnosis of an immunosuppressed patient with nocardiosis has been implicated in treatment failure and poor prognosis.<xref ref-type="bibr" rid="article-25908.r30">[30]</xref> Therefore, if there is suspicion for infection with <italic toggle="yes">Nocardia,</italic> it is imperative to notify the laboratory so that steps can be taken by the laboratory to identify the species and antibiotic sensitivity pattern as quickly as possible. Additionally, the advent of&#x000a0;PCR and 16S rDNA sequencing to identify <italic toggle="yes">Nocardia</italic> species may allow for faster identification and sequencing.<xref ref-type="bibr" rid="article-25908.r24">[24]</xref></p>
      </sec>
      <sec id="article-25908.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Overall, <italic toggle="yes">Nocardia&#x000a0;</italic>is a ubiquitous bacteria that can result in many forms of infection. Infection is more likely in immunocompromised individuals, especially the pulmonary and CNS forms of nocardiosis. Patient's diagnosed with HIV should be aware of the various presentations of Nocardia. TMP-SMX prophylaxis can be given for individuals that are at increased risk for nocardial infection, although there are many strains that are resistant to TMP-SMX as a single agent.</p>
        <p>While immunocompromised individuals are at greatest risk, immunocompetent individuals are also at risk for infection, particularly the cutaneous form of the infection. The main etiology of infection in these patients is due to a skin lesion that was contaminated with organic matter or soil.&#x000a0; Therefore,&#x000a0;a key way to lower the risk of cutaneous nocardiosis is to wear closed shoes and gloves when working in hazardous areas (construction sites, gardens, etc.). If a skin lesion is sustained, it is important to clean the wound thoroughly. If the area becomes red, swollen, and warm or if there is purulent drainage,&#x000a0;a primary care clinician should be consulted.</p>
        <p>In general, <italic toggle="yes">Nocardia</italic> infections are very rare but should be considered if the workup is negative for other common causes of the presenting symptoms.</p>
      </sec>
      <sec id="article-25908.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Nocardial infection often&#x000a0;poses a diagnostic dilemma. Nocardiosis exhibits signs and symptoms that vary greatly based upon the location of the infection (cutaneous, pulmonary, CNS, disseminated).&#x000a0; Additionally, there is a myriad of differential diagnoses that present similarly to nocardial infection and are often more commonly occurring, including fungal and other bacterial etiologies.&#x000a0;The&#x000a0;history and physical exam are important in assessing a patient's risk for nocardiosis. Imaging may allow the clinician to rule down their differential diagnosis honing in on <italic toggle="yes">Nocardia</italic> as a potential source of the infection. The most important diagnostic step is obtaining a sample of the infection (skin biopsy, sputum sample, abscess aspirate) in order to run a gram-stain, acid-fast stain, and culture of the organism. Finally, newer PCR and DNA sequencing methods may allow for a faster species-specific diagnosis.<xref ref-type="bibr" rid="article-25908.r24">[24]</xref></p>
        <p>If the diagnosis of nocardiosis is confirmed, it is important to look for dissemination from the primary source of infection. Patients with <italic toggle="yes">Nocardia</italic> infections are best managed by an interprofessional team. Radiology should be consulted for further workup, which includes brain imaging. Radiologists play an important role as 44% of the time disseminated pulmonary infections are found to have CNS involvement. Brain imaging may reveal one or more cerebral abscesses consistent with CNS nocardiosis.<xref ref-type="bibr" rid="article-25908.r6">[6]</xref>&#x000a0;Finally, infectious disease should be consulted. Due to the increasing resistance of <italic toggle="yes">Nocardia</italic> to TMP-SMX and other sulfonamides, it is important to consult infectious disease specialists for the best combination of antibiotics for the patient.</p>
        <p>Since <italic toggle="yes">Nocardia i</italic>nfections are very rare, there is limited knowledge regarding the outcomes of <italic toggle="yes">Nocardia </italic>treatment.&#x000a0;The outcomes of nocardial infections depend on the site of infection and the immune status of the host. However, to improve outcomes, prompt consultation with an interprofessional group of specialists is recommended so that appropriate treatment can be started.</p>
      </sec>
      <sec id="article-25908.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25908&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25908">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/nocardia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25908">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25908/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25908">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25908.s17">
        <fig id="article-25908.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Nocardia, acid fast stain Contributed by StatPearls</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="20171227_101027" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25908.s18">
        <fig id="article-25908.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Filamentous Nocardia Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nocardia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25908.s19">
        <fig id="article-25908.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Nocardia keratitis Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nocardia__keratitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-25908.s20">
        <fig id="article-25908.image.f4" position="float" orientation="portrait">
          <caption>
            <p>This image depicts the feet, ankles, and lower legs of a patient, who had presented with an infection known as nocardiosis, a form of actinomycosis, due to the bacterium, Nocardia somaliensis, which had affected the left foot and ankle, causing severe swelling and deformation of the normal structural contours. Contributed by the CDC/ Dr. Hardin</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="16183" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25908.s21">
        <title>References</title>
        <ref id="article-25908.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fatahi-Bafghi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis from 1888 to 2017.</article-title>
            <source>Microb Pathog</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>114</volume>
            <fpage>369</fpage>
            <page-range>369-384</page-range>
            <pub-id pub-id-type="pmid">29146497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lerner</surname>
                <given-names>PI</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis.</article-title>
            <source>Clin Infect Dis</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>891</fpage>
            <page-range>891-903; quiz 904-5</page-range>
            <pub-id pub-id-type="pmid">8783685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis: updates and clinical overview.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>403</fpage>
            <page-range>403-7</page-range>
            <pub-id pub-id-type="pmid">22469352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castro</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Nocardia species infections in a large county hospital in Miami: 6 years experience.</article-title>
            <source>J Infect</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>358</fpage>
            <page-range>358-61</page-range>
            <pub-id pub-id-type="pmid">16979760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Conville</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-82</page-range>
            <pub-id pub-id-type="pmid">16614249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beaman</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Beaman</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Nocardia species: host-parasite relationships.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-64</page-range>
            <pub-id pub-id-type="pmid">8055469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahathevan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Forbes</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>O'Grady</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gimson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bragman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Philpott-Howard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Casewell</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, bacteriology and control of an outbreak of Nocardia asteroides infection on a liver unit.</article-title>
            <source>J Hosp Infect</source>
            <year>1991</year>
            <month>Jun</month>
            <volume>18 Suppl A</volume>
            <fpage>473</fpage>
            <page-range>473-80</page-range>
            <pub-id pub-id-type="pmid">1679818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Akhrass</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hachem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tarrand</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kontoyiannis</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ghannoum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haydoura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chaftari</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Raad</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Central venous catheter-associated Nocardia bacteremia in cancer patients.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>1651</fpage>
            <page-range>1651-8</page-range>
            <pub-id pub-id-type="pmid">21888790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ambrosioni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lew</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garbino</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis: updated clinical review and experience at a tertiary center.</article-title>
            <source>Infection</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>89</fpage>
            <page-range>89-97</page-range>
            <pub-id pub-id-type="pmid">20306281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomes</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>La Feria</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Texeira</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title><italic>Nocardia cyriacigeorgica</italic> and <italic>Aspergillus</italic> Co-infection in a Patient with Giant-cell Arteritis.</article-title>
            <source>Eur J Case Rep Intern Med</source>
            <year>2019</year>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>000997</fpage>
            <pub-id pub-id-type="pmid">30756072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saubolle</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sussland</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis: review of clinical and laboratory experience.</article-title>
            <source>J Clin Microbiol</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>41</volume>
            <issue>10</issue>
            <fpage>4497</fpage>
            <page-range>4497-501</page-range>
            <pub-id pub-id-type="pmid">14532173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beaman</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Burnside</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Causey</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Nocardial infections in the United States, 1972-1974.</article-title>
            <source>J Infect Dis</source>
            <year>1976</year>
            <month>Sep</month>
            <volume>134</volume>
            <issue>3</issue>
            <fpage>286</fpage>
            <page-range>286-9</page-range>
            <pub-id pub-id-type="pmid">789786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minero</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Mar&#x000ed;n</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cercenado</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rabad&#x000e1;n</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Bouza</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis at the turn of the century.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>88</volume>
            <issue>4</issue>
            <fpage>250</fpage>
            <page-range>250-261</page-range>
            <pub-id pub-id-type="pmid">19593231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Long</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>A retrospective study of Nocardia infections associated with the acquired immune deficiency syndrome (AIDS).</article-title>
            <source>Infection</source>
            <year>1994</year>
            <season>Sep-Oct</season>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>362</fpage>
            <page-range>362-4</page-range>
            <pub-id pub-id-type="pmid">7843819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peleg</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qureshi</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Silveira</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Sarumi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shutt</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Kwak</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Paterson</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study.</article-title>
            <source>Clin Infect Dis</source>
            <year>2007</year>
            <month>May</month>
            <day>15</day>
            <volume>44</volume>
            <issue>10</issue>
            <fpage>1307</fpage>
            <page-range>1307-14</page-range>
            <pub-id pub-id-type="pmid">17443467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chouci&#x000f1;o</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Goodman</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Greer</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Wolff</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Dummer</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Nocardial infections in bone marrow transplant recipients.</article-title>
            <source>Clin Infect Dis</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>1012</fpage>
            <page-range>1012-9</page-range>
            <pub-id pub-id-type="pmid">8922795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mart&#x000ed;nez Tom&#x000e1;s</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Men&#x000e9;ndez Villanueva</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reyes Calzada</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Santos Durantez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vall&#x000e9;s Tarazona</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Modesto Alapont</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gobernado Serrano</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary nocardiosis: risk factors and outcomes.</article-title>
            <source>Respirology</source>
            <year>2007</year>
            <month>May</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>394</fpage>
            <page-range>394-400</page-range>
            <pub-id pub-id-type="pmid">17539844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conville</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Brown-Elliott</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zelazny</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>The Complexities of Nocardia Taxonomy and Identification.</article-title>
            <source>J Clin Microbiol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29118169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bafghi</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Eshraghi</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Heidarieh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Habibnia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nasab</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis in immune disorder disease.</article-title>
            <source>Malays J Med Sci</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-6</page-range>
            <pub-id pub-id-type="pmid">24639618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Samant</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Nocardiosis in a patient with common variable immunodeficiency.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2006</year>
            <month>Jun</month>
            <volume>54</volume>
            <fpage>495</fpage>
            <page-range>495-6</page-range>
            <pub-id pub-id-type="pmid">16909702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gotoff</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Foltzer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Storm</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bourbeau</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Implantable defibrillator pocket infection and bacteremia caused by Nocardia nova complex isolate.</article-title>
            <source>J Clin Microbiol</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>11</issue>
            <fpage>5325</fpage>
            <page-range>5325-6</page-range>
            <pub-id pub-id-type="pmid">14605196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Deville</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nielsen</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Nocardia asteroides brain abscesses and meningitis in an immunocompromized 10-year-old child.</article-title>
            <source>Scand J Infect Dis</source>
            <year>2005</year>
            <volume>37</volume>
            <issue>6-7</issue>
            <fpage>511</fpage>
            <page-range>511-3</page-range>
            <pub-id pub-id-type="pmid">16012015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kreppel</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Brady</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Fouladi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hummel</surname>
                <given-names>TR</given-names>
              </name>
            </person-group>
            <article-title>Nocardia farcinica Meningitis Masquerading as Central Nervous System Metastasis in a Child With Cerebellar Pilocytic Astrocytoma.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>482</fpage>
            <page-range>482-5</page-range>
            <pub-id pub-id-type="pmid">26181420</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sonesson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oqvist</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hagstam</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bj&#x000f6;rkman-Burtscher</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Mi&#x000f6;rner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Petersson</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>An immunosuppressed patient with systemic vasculitis suffering from cerebral abscesses due to Nocardia farcinica identified by 16S rRNA gene universal PCR.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>2896</fpage>
            <page-range>2896-900</page-range>
            <pub-id pub-id-type="pmid">15496565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallace</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Septimus</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Musher</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Berger</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Treatment of experimental nocardiosis in mice: comparison of amikacin and sulfonamide.</article-title>
            <source>J Infect Dis</source>
            <year>1979</year>
            <month>Aug</month>
            <volume>140</volume>
            <issue>2</issue>
            <fpage>244</fpage>
            <page-range>244-8</page-range>
            <pub-id pub-id-type="pmid">383855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lerner</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial susceptibility of Nocardia species.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1973</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-93</page-range>
            <pub-id pub-id-type="pmid">4790942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gombert</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Aulicino</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>duBouchet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Sheinbaum</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1986</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>270</fpage>
            <page-range>270-3</page-range>
            <pub-id pub-id-type="pmid">3532945</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smego</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Moeller</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Gallis</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Trimethoprim-sulfamethoxazole therapy for Nocardia infections.</article-title>
            <source>Arch Intern Med</source>
            <year>1983</year>
            <month>Apr</month>
            <volume>143</volume>
            <issue>4</issue>
            <fpage>711</fpage>
            <page-range>711-8</page-range>
            <pub-id pub-id-type="pmid">6340623</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lavalard</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Guillard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Baumard</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grillon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brasme</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Nava</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Litr&#x000e9;</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Delmer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boiron</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Champs</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>[Brain abscess due to Nocardia cyriacigeorgica simulating an ischemic stroke].</article-title>
            <source>Ann Biol Clin (Paris)</source>
            <year>2013</year>
            <season>May-Jun</season>
            <volume>71</volume>
            <issue>3</issue>
            <fpage>345</fpage>
            <page-range>345-8</page-range>
            <pub-id pub-id-type="pmid">23747674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25908.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ozgen&#x000e7;</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Avc&#x00131;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ar&#x00131;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Celebi</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Co&#x0015f;kuner</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Long-term treatment of persistent disseminated Nocardia cyriacigeorgica infection.</article-title>
            <source>Braz J Infect Dis</source>
            <year>2014</year>
            <season>Sep-Oct</season>
            <volume>18</volume>
            <issue>5</issue>
            <fpage>556</fpage>
            <page-range>556-60</page-range>
            <pub-id pub-id-type="pmid">24833199</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
